Ticker: CVRX

CVRx, Inc. (NASDAQ: CVRX) is focused on developing and commercializing innovative neuromodulation solutions for cardiovascular disease, particularly through its flagship product, Barostim. The company's recent quarterly report for the period ending June 30, 2025, highlights several key developmen...